OROS Hydromorphone Development Unaffected By Palladone Withdrawal, J&J Says

Johnson & Johnson says that the withdrawal of Purdue Pharma's Palladone (hydromorphone extended release) will not affect development of its OROS hydromorphone opioid analgesic